These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 21881574

  • 1. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
    Shimizu H, Nakagami H, Yasumasa N, Mariana OK, Kyutoku M, Koriyama H, Nakagami F, Shimamura M, Rakugi H, Morishita R.
    Hypertens Res; 2012 Jan; 35(1):77-81. PubMed ID: 21881574
    [Abstract] [Full Text] [Related]

  • 2. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 3. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
    Soeki T, Kitani M, Kusunose K, Yagi S, Taketani Y, Koshiba K, Wakatsuki T, Orino S, Kawano K, Sata M.
    Hypertens Res; 2012 Nov; 35(11):1058-62. PubMed ID: 22763473
    [Abstract] [Full Text] [Related]

  • 4. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Ogura C, Ono K, Miyamoto S, Ikai A, Mitani S, Sugimoto N, Tanaka S, Fujita M.
    Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S, Harada E, Sugino K, Nishimura M, Nakamura T, Takahara A.
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
    [Abstract] [Full Text] [Related]

  • 6. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
    Konda T, Enomoto A, Aritomi S, Niinuma K, Koganei H, Ogawa T, Nitta K.
    Am J Nephrol; 2009 Apr; 30(2):155-61. PubMed ID: 19325231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
    Hoshide S, Kario K, Ishikawa J, Eguchi K, Shimada K.
    Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
    [Abstract] [Full Text] [Related]

  • 9. Involvement of N-type Ca(2+) channels in the fibrotic process of the kidney in rats.
    Mishima K, Maeshima A, Miya M, Sakurai N, Ikeuchi H, Hiromura K, Nojima Y.
    Am J Physiol Renal Physiol; 2013 Mar 15; 304(6):F665-73. PubMed ID: 23324177
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats.
    Halici Z, Borekci B, Ozdemir Y, Cadirci E, Suleyman H.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):241-5. PubMed ID: 17936271
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.
    Masuda T, Ogura MN, Moriya T, Takahira N, Matsumoto T, Kutsuna T, Hara M, Aiba N, Noda C, Izumi T.
    Cardiovasc Ther; 2011 Feb 28; 29(1):46-53. PubMed ID: 20337636
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    Ando K, Ueshima K, Tanaka S, Kosugi S, Sato T, Matsuoka H, Nakao K, Fujita T.
    Int J Med Sci; 2013 Feb 28; 10(9):1209-16. PubMed ID: 23935398
    [Abstract] [Full Text] [Related]

  • 18. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats.
    Yamamoto E, Kataoka K, Dong YF, Nakamura T, Fukuda M, Nako H, Ogawa H, Kim-Mitsuyama S.
    J Hypertens; 2010 Jun 28; 28(6):1321-9. PubMed ID: 20224431
    [Abstract] [Full Text] [Related]

  • 19. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2004 Jun 28; 18(3):309-19. PubMed ID: 15147282
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.